Correlation Between Neuropace and Rxsight

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Rxsight at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Rxsight into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Rxsight, you can compare the effects of market volatilities on Neuropace and Rxsight and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Rxsight. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Rxsight.

Diversification Opportunities for Neuropace and Rxsight

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Neuropace and Rxsight is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Rxsight in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rxsight and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Rxsight. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rxsight has no effect on the direction of Neuropace i.e., Neuropace and Rxsight go up and down completely randomly.

Pair Corralation between Neuropace and Rxsight

Given the investment horizon of 90 days Neuropace is expected to generate 1.42 times more return on investment than Rxsight. However, Neuropace is 1.42 times more volatile than Rxsight. It trades about 0.06 of its potential returns per unit of risk. Rxsight is currently generating about -0.13 per unit of risk. If you would invest  1,087  in Neuropace on December 30, 2024 and sell it today you would earn a total of  98.00  from holding Neuropace or generate 9.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Rxsight

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Rxsight 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Rxsight has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Neuropace and Rxsight Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Rxsight

The main advantage of trading using opposite Neuropace and Rxsight positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Rxsight can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rxsight will offset losses from the drop in Rxsight's long position.
The idea behind Neuropace and Rxsight pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities